Inhibition of both c-Met and EGFR signaling shows synergistic antitumor activity in non-small cell lung cancer model

被引：1
|
作者：
Tammam, Jennifer G.
Davis, Lenora
Ware, Chris
Reilly, John F.
Deshmukh, Sujal V.
Dinsmore, Christopher
Marshall, Gary
Harrington, Elizabeth A.
Pan, Bo-Sheng
Lutterbach, Bart A.
Majumder, Pradip K.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-C209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C209
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer
    Crees, Zachary D.
    Shearrow, Caleb
    Lin, Leo
    Girard, Jennifer
    Arasi, Kavin
    Bhoraskar, Aayush
    Berei, Joseph
    Eckburg, Adam
    Anderson, Austin D.
    Garcia, Christian
    Munger, Ariana
    Palani, Sunil
    Smith, Thomas J.
    Sreenivassappa, Shylendra B.
    Vitali, Connie
    David, Odile
    Puri, Neelu
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [2] Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer
    Jeong, Mi-So
    Lee, Kang-Wook
    Choi, Yu-Jeong
    Kim, Yun-Gyeong
    Hwang, Hyun-Ha
    Lee, Seo-Yeon
    Jung, Se-Eun
    Park, Sun-Ah
    Lee, Jin-Hee
    Joo, Yong-Joon
    Cho, Sung-Gook
    Ko, Seong-Gyu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [3] Mechanism of EGFR and c-Met TKI resistance and role of co-expression of EGFR and c-Met in non-small cell lung cancer patients
    Botting, Gregory Michael
    Harrington, Kymberly
    Shearrow, Caleb
    Crees, Zachary
    Girard, Jennifer
    Arasi, Kavin
    Puri, Neelu
    CANCER RESEARCH, 2014, 74 (19)
  • [4] C-MET inhibitors for advanced non-small cell lung cancer
    Pasquini, Giulia
    Giaccone, Giuseppe
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 363 - 375
  • [5] Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer
    Fu, Le
    Guo, Wei
    Liu, Bingshan
    Sun, Linlin
    Bi, Zhenghong
    Zhu, Li
    Wang, Xinyan
    Liu, Bin
    Xie, Qian
    Li, Ke
    BIOMARKERS, 2013, 18 (02) : 126 - 135
  • [6] Antitumor Activity of DFX117 by Dual Inhibition of c-Met and PI3Kα in Non-Small Cell Lung Cancer
    Fan, Yanhua
    Ding, Huaiwei
    Kim, Donghwa
    Bach, Duc-Hiep
    Hong, Ji-Young
    Xu, Yongnan
    Lee, Sang Kook
    CANCERS, 2019, 11 (05)
  • [7] Expression profiles of EGFR, c-Met, and mTOR/Wnt alternative signaling pathway proteins in non-small cell lung cancer
    Shearrow, Caleb
    Crees, Zachary
    Girard, Jennifer
    Harrington, Kymberly
    Arasi, Kavin
    Bertram, Ceyda
    Nowak, Andrew
    Lin, Leo
    Sheu, Bonnie
    Palani, Sunil
    Puri, Neelu
    CANCER RESEARCH, 2015, 75
  • [8] Synergistic antitumor activity of low-dose c-Met tyrosine kinase inhibitor and sorafenib on human non-small cell lung cancer cells
    Fu, Ling
    Guo, Liang
    Zheng, Yi
    Zhu, Zhenyu
    Zhang, Mingyue
    Zhao, Xiaohua
    Cui, Hongxue
    ONCOLOGY LETTERS, 2018, 15 (04) : 5081 - 5086
  • [9] Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment
    Yao, Shuxi
    Liu, Xinyue
    Feng, Yanqi
    Li, Yiming
    Xiao, Xiangtian
    Han, Yuelin
    Xia, Shu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [10] c-Met antibody LY2875358 (LA480) shows differential antitumor effects in non-small cell lung cancer
    Zeng, Wei
    Yan, Lei
    Peek, Victoria
    Wortinger, Mark
    Tetreault, Jonathan
    Xia, Jinqi
    Chow, Chi-Kin
    Manro, Jason R.
    Stephens, Jennifer R.
    Weir, Spring N.
    Tang, Ying
    Vaillancourt, Peter
    Lu, Jirong
    Yan, Betty S.
    Liu, Ling
    CANCER RESEARCH, 2012, 72
12345